Dr. Mei is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Division of Lymphoma
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-389-3059- Is this information wrong?
Education & Training
Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 2011 - 2014
University of California (San Francisco)Residency, Internal Medicine, 2007 - 2010
Case Western Reserve University School of MedicineClass of 2007
Certifications & Licensure
CA State Medical License 2009 - 2024- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) Start of enrollment: 2012 Oct 31
- RITUXIMAB + IMMUNOTHERAPY IN FOLLICULAR LYMPHOMA Start of enrollment: 2018 Oct 30
- Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy Start of enrollment: 2022 Jul 25
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin Lymphoma.Ni-Chun Tsai, Joycelynne Palmer, Matthew Mei, Saro Armenian, Robert Chen, Steven Rosen, Stephen Forman, Leslie Popplewell, Larry Kwak, Peter Martin, Kami Maddocks, Dav...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Apr 10
- Role of Radiation in Combination With CD30-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Hodgkin Lymphoma.Hao, C., Ladbury, C., Mei, M., Herrera, A., Green, G., Dandapani, S.> ;Advances in Radiation Oncology. 2024 Apr 1
- Coronary artery calcium and cardiovascular outcomes in patients with lymphoma undergoing autologous hematopoietic cell transplantation.Wu, S., Rhee, J., Iukuridze, A., Bosworth, A., Chen, S., Atencio, L., Manubolu, V., Bhandari, R., Jamal, F., Mei, M., Herrera, A., Rodriguez, F., Forman, S., Nakamura,...> ;Cancer. 2024 Feb 15
- Join now to see all
Abstracts/Posters
- Peri-Transplant Administration of Ruxolitinib Is Safe and Feasible in Patients with Myelofibrosis: Primary Results of a Pilot Open-Label Study of Ruxolitinib Administr...Matthew Mei, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab in Patients with Hodgkin Lymphoma Aged _60 YearsClinically Relevant AbstractMatthew Mei, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Long Term Outcomes of Patients with Aggressive T-Cell Non-Hodgkin Lymphoma Undergoing Allogeneic Stem Cell Transplantation: Retrospective Results from a Single CenterMatthew Mei, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Phase 1 Study of MDR1 Inhibitor Plus Brentuximab Vedotin in Relapsed/Refractory Hodgkin Lymphoma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
City of Hope Doctors Present New Research on Cancer ImmunotherapiesNovember 4th, 2021
City of Hope Doctors Present Research on New Immunotherapies at American Society of Hematology ConferenceDecember 9th, 2019
Maintenance Rituximab Post-ASCT Associated with Improved OS in MCLSeptember 19th, 2017
Other Languages
- Chinese (Mandarin), Spanish
Hospital Affiliations
City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
